- Sections
- C - Chimie; métallurgie
- C07K - Peptides
- C07K 14/635 - Hormone parathyroïdienne (parathormone); Peptides dérivés de l'hormone parathyroïdienne
Détention brevets de la classe C07K 14/635
Brevets de cette classe: 208
Historique des publications depuis 10 ans
|
15
|
15
|
18
|
7
|
23
|
19
|
17
|
21
|
7
|
4
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1144 |
30 |
| The General Hospital Corporation | 4517 |
12 |
| Board of Trustees of the University of Arkansas | 771 |
10 |
| National University Corporation Kagawa University | 213 |
8 |
| Ochsner Clinic Foundation | 23 |
7 |
| Radius Health, Inc. | 94 |
7 |
| ALZA Corporation | 184 |
4 |
| Hybio Pharmaceutical Co., Ltd. | 119 |
4 |
| Wisconsin Alumni Research Foundation | 3774 |
3 |
| Takeda Pharmaceutical Company Limited | 2961 |
3 |
| Purdue Research Foundation | 3277 |
3 |
| Asahi Kasei Pharma Corporation | 144 |
3 |
| Cadila Healthcare Limited | 341 |
3 |
| Chemical & Biopharmaceutical Laboratories of Patras S.A. | 29 |
3 |
| Eli Lilly and Company | 3645 |
3 |
| Indiana University Research and Technology Corporation | 808 |
3 |
| The Kitasato Institute | 146 |
3 |
| Kuros Biosurgery AG | 29 |
3 |
| Kindeva Drug Delivery L.P., Kindeva GP II LLC, a Delaware limited liability company | 220 |
3 |
| Amgen Inc. | 3779 |
2 |
| Autres propriétaires | 91 |